A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 344 participants.
Also called NCT07438444
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 344 participants
- Sponsor
- Registry
-
NCT07438444
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07438444. Allocation not applicable; no masking; primary purpose treatment. Start 2026-02-27 (actual); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Obesity
- Condition
- Overweight
- Intervention (Drug)
- Tirzepatide
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct07438444- Content hash
246a279817de31c80e1855b569ac1a3a0656a3898f0083789d8b794867f7e44e